NNA - Russia said Monday it aims to launch mass production of a coronavirus vaccine next month and turn out "several million" doses per month by next year.
The country is pushing ahead with several vaccine prototypes and one prepared at the Gamaleya institute in Moscow has reached advanced stages of development.
"We are very much counting on starting mass production in September," industry minister Denis Manturov said in an interview published by TASS news agency.
"We will be able to ensure production volumes of several hundred thousand a month, with an eventual increase to several million by the start of next year," he said, adding that one developer is preparing production technology at three locations in central Russia.
Health Minister Mikhail Murashko on Saturday said the Gamaleya vaccine had "completed clinical trials" and that documents were being prepared to register it with the state.
Another vaccine, developed by Siberia-based Vektor lab, is currently undergoing clinical trials and two more will begin human testing within the next two months, Murashko said.
Gamaleya’s vaccine is a so-called viral vector vaccine, meaning it employs another virus to carry the DNA encoding of the needed immune response into cells.--AFP